SEC Form 4 · accession 0001567619-19-002402
KalVista Pharmaceuticals, Inc. · KALV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian JG Pereira
Director
Period of report
Feb 1, 2019
Accepted (ET)
Feb 5, 2019 · 5:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001348911
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (Right to Buy)F1 | $17.95 | Feb 1, 2019 | A | 14,000 | A | — | Jan 31, 2029 | Common Stock | 14,000 | 14,000 | D |
Explanation of responses
- F1The option vests over a 3 year period: 1/36th vests on March 1, 2019, after which 1/36th of the total shares vest monthly, subject to reporting person's continued service through each vesting date.